DGAP-News
MOLOGEN AG: Public rights offering of convertible bonds with purchase guarantee by major shareholder - Seite 2
should offer a convertible bond to all shareholders. The new bond is also
to yield interest of 6% p.a., with quarterly payments. From April 1, 2017,
it will be possible to convert the bond at any time - with the exception of
a few periods of time - into a maximum of 3,124,994 shares of the company
at a conversion price of EUR1.60. Issuance and delivery of the convertible
bond is scheduled to take place on January 20, 2017. The funds inflow is to
be used for the ongoing implementation of the "Next Level" strategy program
and specifically the further development of the lead product, the
immunotherapy with lefitolimod. Furthermore, the additional funds inflows
will give the company greater financial scope for implementing and securing
other strategic and operating measures in 2017. In addition, the company is
in a stronger position for upcoming potential negotiations in partnering
and licensing talks. According to current plans, financing is secured until
the beginning of 2018.
The subscription period of around two weeks is expected to last from
December 28, 2016 up to and including January 13, 2017. Shareholders will
be informed accordingly by their custodian banks. Further details will be
provided in the rights offering, which is scheduled for publication on
December 27, 2016 in the Federal Gazette and additionally on the company's
website at www.mologen.com.
Dero Bank, Munich, Germany is the sole bookrunner for this transaction.
Blättchen Financial Advisory GmbH supports MOLOGEN on the transaction as an
advisor.
Walter Miller, Chief Financial Officer of MOLOGEN AG, explains: "In our
talks on the recently implemented capital increase, investors expressed an
interest in a convertible bond with similar features to those of the
convertible bond issue which was also recently subscribed in full by GDT.
We want to benefit from this positive momentum and are offering our
shareholders a convertible bond with a similar structure for subscription.
We are delighted that our major shareholder will once again considerably
support this capital measure.
In November 2016, the company implemented its first convertible bond issue
with a nominal amount of EUR2.54 million, which was taken over in full by
major shareholder GDT, excluding shareholders' subscription rights. The
convertible bond features a maturity of eight years and fixed annual
interest of 6% as well as the investor's right to convert the convertible
bonds into a maximum of 1,693,333 shares of the company through partial
utilization of contingent capital at a conversion price of EUR1.50. In
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte